Apyx Medical Corporation

NasdaqGS:APYX Stock Report

Market Cap: US$59.1m

Apyx Medical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Charlie Goodwin

Chief executive officer

US$1.3m

Total compensation

CEO salary percentage38.2%
CEO tenure7yrs
CEO ownership0.2%
Management average tenureless than a year
Board average tenure5.4yrs

Recent management updates

We Discuss Why Apyx Medical Corporation's (NASDAQ:APYX) CEO Compensation May Be Closely Reviewed

Aug 01
We Discuss Why Apyx Medical Corporation's (NASDAQ:APYX) CEO Compensation May Be Closely Reviewed

Recent updates

Is Now The Time To Look At Buying Apyx Medical Corporation (NASDAQ:APYX)?

Dec 19
Is Now The Time To Look At Buying Apyx Medical Corporation (NASDAQ:APYX)?

Apyx Medical Corporation (NASDAQ:APYX) Surges 30% Yet Its Low P/S Is No Reason For Excitement

Nov 23
Apyx Medical Corporation (NASDAQ:APYX) Surges 30% Yet Its Low P/S Is No Reason For Excitement

Is There An Opportunity With Apyx Medical Corporation's (NASDAQ:APYX) 41% Undervaluation?

Sep 14
Is There An Opportunity With Apyx Medical Corporation's (NASDAQ:APYX) 41% Undervaluation?

Apyx Medical Corporation (NASDAQ:APYX) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Aug 07
Apyx Medical Corporation (NASDAQ:APYX) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

We Discuss Why Apyx Medical Corporation's (NASDAQ:APYX) CEO Compensation May Be Closely Reviewed

Aug 01
We Discuss Why Apyx Medical Corporation's (NASDAQ:APYX) CEO Compensation May Be Closely Reviewed

Is Apyx Medical (NASDAQ:APYX) Using Debt In A Risky Way?

Jun 19
Is Apyx Medical (NASDAQ:APYX) Using Debt In A Risky Way?

Revenues Working Against Apyx Medical Corporation's (NASDAQ:APYX) Share Price Following 25% Dive

Apr 18
Revenues Working Against Apyx Medical Corporation's (NASDAQ:APYX) Share Price Following 25% Dive

Apyx Medical Corporation (NASDAQ:APYX) Analysts Just Slashed This Year's Estimates

Mar 26
Apyx Medical Corporation (NASDAQ:APYX) Analysts Just Slashed This Year's Estimates

Take Care Before Diving Into The Deep End On Apyx Medical Corporation (NASDAQ:APYX)

Feb 16
Take Care Before Diving Into The Deep End On Apyx Medical Corporation (NASDAQ:APYX)

Is Apyx Medical (NASDAQ:APYX) A Risky Investment?

Sep 14
Is Apyx Medical (NASDAQ:APYX) A Risky Investment?

Does Apyx Medical (NASDAQ:APYX) Have A Healthy Balance Sheet?

Jun 07
Does Apyx Medical (NASDAQ:APYX) Have A Healthy Balance Sheet?

Forecast: Analysts Think Apyx Medical Corporation's (NASDAQ:APYX) Business Prospects Have Improved Drastically

Mar 21
Forecast: Analysts Think Apyx Medical Corporation's (NASDAQ:APYX) Business Prospects Have Improved Drastically

Here's Why We're Watching Apyx Medical's (NASDAQ:APYX) Cash Burn Situation

Dec 14
Here's Why We're Watching Apyx Medical's (NASDAQ:APYX) Cash Burn Situation

We're Not Very Worried About Apyx Medical's (NASDAQ:APYX) Cash Burn Rate

Aug 30
We're Not Very Worried About Apyx Medical's (NASDAQ:APYX) Cash Burn Rate

CEO Compensation Analysis

How has Charlie Goodwin's remuneration changed compared to Apyx Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$28m

Jun 30 2024n/an/a

-US$28m

Mar 31 2024n/an/a

-US$23m

Dec 31 2023US$1mUS$483k

-US$19m

Sep 30 2023n/an/a

-US$15m

Jun 30 2023n/an/a

-US$16m

Mar 31 2023n/an/a

-US$21m

Dec 31 2022US$2mUS$483k

-US$23m

Sep 30 2022n/an/a

-US$19m

Jun 30 2022n/an/a

-US$18m

Mar 31 2022n/an/a

-US$16m

Dec 31 2021US$2mUS$450k

-US$15m

Sep 30 2021n/an/a

-US$15m

Jun 30 2021n/an/a

-US$14m

Mar 31 2021n/an/a

-US$15m

Dec 31 2020US$2mUS$450k

-US$12m

Sep 30 2020n/an/a

-US$16m

Jun 30 2020n/an/a

-US$16m

Mar 31 2020n/an/a

-US$16m

Dec 31 2019US$2mUS$450k

-US$20m

Sep 30 2019n/an/a

-US$18m

Jun 30 2019n/an/a

-US$15m

Mar 31 2019n/an/a

-US$14m

Dec 31 2018US$1mUS$400k

-US$11m

Sep 30 2018n/an/a

-US$10m

Jun 30 2018n/an/a

-US$12m

Mar 31 2018n/an/a

-US$15m

Dec 31 2017US$2mUS$15k

-US$14m

Compensation vs Market: Charlie's total compensation ($USD1.26M) is above average for companies of similar size in the US market ($USD653.16K).

Compensation vs Earnings: Charlie's compensation has been consistent with company performance over the past year.

CEO

Charlie Goodwin (58 yo)

7yrs

Tenure

US$1,261,470

Compensation

Mr. Charles D. Goodwin II, also known as Charlie, has been Chief Executive Officer and Director of Apyx Medical Corporation (formerly known as Bovie Medical Corporation) since December 15, 2017 and serves...

Leadership Team

NamePositionTenureCompensationOwnership
Charles Goodwin
President7yrsUS$1.26m0.24%
$ 141.3k
Matthew Hill
CFO, Treasurer & Secretaryless than a yearUS$445.95k0.021%
$ 12.3k
Moshe Citronowicz
Senior Vice President12.9yrsUS$538.31k1.21%
$ 716.7k
Stavros Vizirgianakis
Executive Chairmanless than a yearno data4.64%
$ 2.7m
Shawn Roman
Chief Operating Officerless than a yearno datano data

1.0yrs

Average Tenure

55yo

Average Age

Experienced Management: APYX's management team is not considered experienced ( 1 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Charles Goodwin
President7yrsUS$1.26m0.24%
$ 141.3k
Stavros Vizirgianakis
Executive Chairmanless than a yearno data4.64%
$ 2.7m
Lawrence Waldman
Lead Independent Director13.8yrsUS$162.56k0.11%
$ 67.4k
Brian Kinney
Member of Medical Advisory Board5.4yrsno datano data
Gregory Konesky
Member of Scientific Advisory Boardno dataUS$9.30kno data
Yuval Carmel
Member of Scientific Advisory Boardno datano datano data
Minnie Baylor-Henry
Independent Director5.3yrsUS$116.56k0%
$ 0
Dennis Chi
Member of Medical Advisory Board7.9yrsno datano data
Diane Duncan
Member of Medical Advisory Board6.6yrsno datano data
Paul Ruff
Member of Medical Advisory Board5.4yrsno datano data
Richard Gentile
Member of Medical Advisory Board5.4yrsno datano data
Edward Zimmerman
Member of Medical Advisory Board5.4yrsno datano data

5.4yrs

Average Tenure

69yo

Average Age

Experienced Board: APYX's board of directors are considered experienced (5.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 08:52
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Apyx Medical Corporation is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sam EiberBTIG
Matthew HewittCraig-Hallum Capital Group LLC
David TurkalyJMP Securities